85-5737-55　[N-[(1S,2S)-2-(Amino-κN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato(2-)-κN][(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]rutheniumNoyori Catalyst 250mg　457498

特徴

• [N-[(1S,2S)-2-(Amino-κN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato(2-)-κN][(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]ruthenium is a coordination compound used in the synthesis of Resolvin E1 Sodium Salt (R144690), which is an omega-3 polyunsaturated fatty acid derivative that exhibits potent anti-inflammatory, pro-resolution, and anti-nociceptive effects. Resolvin E1 has been shown to inhibit neuropathic pain and spinal cord microgial activation following peripheral nerve injury.
• Molecular Formula:C31H34N2O2RuS
• Solubility:DMSO, Methanol
• Molecular Weight:559.75
• Storage and Stability:Store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

仕様

• Size：250mg
• Grade：Highly Purified
• Form：Supplied as a Solid Purple
• Molecular Formula：C31H34N2O2RuS
• Molecular Weight Non Ab：559.75
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]